User Visitor Login
English only
EPFL > FSV > BBP > Channelpedia
Ion channels
Logged in as a Visitor.

All references automaticaly matched for Cav2.3

138. Pubmed Berecki G. et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H. Neuropharmacology, 2016 May 28 , 109 (49-58).
137. Pubmed Berecki G. et al. Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits. Mol. Pharmacol., 2016 Jan , 89 (187-96).
136. Pubmed Castro J. et al. α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors. Gut, 2016 Feb 17 , ().
135. Pubmed Ye F. et al. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases. Toxins (Basel), 2016 , 8 ().
134. Pubmed Bragança B. et al. Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria. Front Pharmacol, 2016 , 7 (45).
133. Pubmed Goedicke-Fritz S. et al. Evidence for functional and dynamic microcompartmentation of Cav-1/TRPV4/K(Ca) in caveolae of endothelial cells. Eur. J. Cell Biol., 2015 Jul-Sep , 94 (391-400).
132. Pubmed Kumar D. et al. Cacna1c (Cav1.2) Modulates Electroencephalographic Rhythm and Rapid Eye Movement Sleep Recovery. Sleep, 2015 Sep , 38 (1371-80).
131. Pubmed Park S. et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).
130. Pubmed Siapich S. et al. Low concentrations of ethanol but not of dimethyl sulfoxide (DMSO) impair reciprocal retinal signal transduction. Graefes Arch. Clin. Exp. Ophthalmol., 2015 Oct , 253 (1713-9).
129. Pubmed Rousset M. et al. Regulation of neuronal high-voltage activated Ca(V)2 Ca(2+) channels by the small GTPase RhoA. Neuropharmacology, 2015 Oct , 97 (201-9).
128. Pubmed Neumaier F. et al. Voltage-gated calcium channels: Determinants of channel function and modulation by inorganic cations. Prog. Neurobiol., 2015 Mar 25 , ().
127. Pubmed Long Y. et al. Genome-wide association study identifies QTLs for EBV of backfat thickness and average daily gain in Duroc pigs. Genetika, 2015 Mar , 51 (371-8).
126. Pubmed Weiergräber M. et al. A scientific assessment of CaV2.3 voltage-gated Ca2+ channels in rodent sleep architecture. Sleep, 2015 Mar , 38 (501-2).
125. Pubmed Schneider T. et al. Cav2.3 E-/R-type voltage-gated calcium channels modulate sleep in mice. Sleep, 2015 Mar , 38 (499).
124. Pubmed Tompkins J. et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability. Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).
123. Pubmed Dibué-Adjei M. et al. In response: Cav2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo. Epilepsia, 2015 Jul , 56 (1181).
122. Pubmed Mishra R. et al. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels. J. Cardiovasc. Pharmacol., 2015 Jul , 66 (118-27).
121. Pubmed Padula A. et al. KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction. Neuropsychopharmacology, 2015 Jul , 40 (1928-39).
120. Pubmed Drobinskaya I. et al. Diethyldithiocarbamate-mediated zinc ion chelation reveals role of Cav2.3 channels in glucagon secretion. Biochim. Biophys. Acta, 2015 Jan 17 , 1853 (953-964).
119. Pubmed Matolcsi M. et al. A novel explanation for observed CaMKII dynamics in dendritic spines with added EGTA or BAPTA. Biophys. J., 2015 Feb 17 , 108 (975-85).
118. Pubmed Licon Y. et al. Inhibition of CaV2.3 channels by NK1 receptors is sensitive to membrane cholesterol but insensitive to caveolin-1. Pflugers Arch., 2015 Aug , 467 (1699-709).
117. Pubmed Waeckel L. et al. Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure. Pflugers Arch., 2015 Apr , 467 (817-31).
116. Pubmed Schneider T. et al. R-Type Voltage-Gated Ca(2+) Channels in Cardiac and Neuronal Rhythmogenesis. Curr Mol Pharmacol, 2015 , 8 (102-8).
115. Pubmed Dallérac G. et al. Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels. Neurodegener Dis, 2015 , 15 (93-108).
114. Pubmed Wang K. et al. Apamin Boosting of Synaptic Potentials in CaV2.3 R-Type Ca2+ Channel Null Mice. PLoS ONE, 2015 , 10 (e0139332).
113. Pubmed Klint J. et al. Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels. Biochem. Pharmacol., 2014 May 15 , 89 (276-86).
112. Pubmed Climent B. et al. Effects of obesity on vascular potassium channels. Curr Vasc Pharmacol, 2014 May , 12 (438-52).
111. Pubmed Siwek M. et al. The CaV2.3 R-type voltage-gated Ca2+ channel in mouse sleep architecture. Sleep, 2014 May , 37 (881-92).
110. Pubmed Jan W. et al. Exploring the associations between genetic variants in genes encoding for subunits of calcium channel and subtypes of bipolar disorder. J Affect Disord, 2014 Mar , 157 (80-6).
109. Pubmed Coleman N. et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1. Mol. Pharmacol., 2014 Jun 23 , ().
108. Pubmed Ricoy U. et al. Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. J. Neurophysiol., 2014 Jun 15 , 111 (2404-13).
107. Pubmed Kimm T. et al. Inhibition of A-type potassium current by the peptide toxin SNX-482. J. Neurosci., 2014 Jul 9 , 34 (9182-9).
106. Pubmed Wang K. et al. Distinct Ca2+ sources in dendritic spines of hippocampal CA1 neurons couple to SK and Kv4 channels. Neuron, 2014 Jan 22 , 81 (379-87).
105. Pubmed Satake S. et al. Cav2.1 channels control multivesicular release by relying on their distance from exocytotic Ca2+ sensors at rat cerebellar granule cells. J. Neurosci., 2014 Jan 22 , 34 (1462-74).
104. Pubmed Zaman T. et al. LMO4 is essential for paraventricular hypothalamic neuronal activity and calcium channel expression to prevent hyperphagia. J. Neurosci., 2014 Jan 1 , 34 (140-8).
103. Pubmed Qian X. et al. Positive feedback regulation of agonist-stimulated endothelial Ca2+ dynamics by KCa3.1 channels in mouse mesenteric arteries. Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (127-35).
102. Pubmed Cohen R. et al. Lipid modulation of calcium flux through CaV2.3 regulates acrosome exocytosis and fertilization. Dev. Cell, 2014 Feb 10 , 28 (310-21).
101. Pubmed Zhao L. et al. Advanced glycation end products impair K(Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries. Pflugers Arch., 2014 Feb , 466 (307-17).
100. Pubmed Berecki G. et al. Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation. J. Gen. Physiol., 2014 Apr , 143 (465-79).
99. Pubmed Perez-Reyes E. et al. Ins and outs of T-channel structure function. Pflugers Arch., 2014 Apr , 466 (627-33).
98. Pubmed Wandall-Frostholm C. et al. Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels. PLoS ONE, 2014 , 9 (e97687).
97. Pubmed Berrout J. et al. Emerging role of the calcium-activated, small conductance, SK3 K+ channel in distal tubule function: regulation by TRPV4. PLoS ONE, 2014 , 9 (e95149).
96. Pubmed Tevoufouet E. et al. Cardiac functions of voltage-gated Ca(2+) channels: role of the pharmacoresistant type (E-/R-Type) in cardiac modulation and putative implication in sudden unexpected death in epilepsy (SUDEP). Rev. Physiol. Biochem. Pharmacol., 2014 , 167 (115-39).
95. Pubmed Janbein M. et al. Evidence for the interaction of endophilin a3 with endogenous Kca2.3 channels in PC12 cells. Cell. Physiol. Biochem., 2014 , 34 (474-90).
94. Pubmed Siddiqui T. et al. Expression and contributions of TRPM7 and KCa2.3/SK3 channels to the increased migration and invasion of microglia in anti-inflammatory activation states. PLoS ONE, 2014 , 9 (e106087).
93. Pubmed Cox R. et al. A naturally occurring truncated Cav1.2 α1-subunit inhibits Ca2+ current in A7r5 cells. Am. J. Physiol., Cell Physiol., 2013 Oct 15 , 305 (C896-905).
92. Pubmed Ramachandra R. et al. Identification of CaV channel types expressed in muscle afferent neurons. J. Neurophysiol., 2013 Oct , 110 (1535-43).
91. Pubmed Rozanski G. et al. Low voltage-activated calcium channels gate transmitter release at the dorsal root ganglion sandwich synapse. J. Physiol. (Lond.), 2013 Nov 15 , 591 (5575-83).
90. Pubmed Liu B. et al. Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole. J Neuroimmune Pharmacol, 2013 Mar , 8 (227-37).
89. Pubmed Takai J. et al. Laminar shear stress upregulates endothelial Ca2+-activated K+ channels KCa2.3 and KCa3.1 via a Ca2+/calmodulin-dependent protein kinase kinase/Akt/p300 cascade. Am. J. Physiol. Heart Circ. Physiol., 2013 Jun 21 , ().
88. Pubmed Ma X. et al. Functional role of TRPV4-KCa2.3 signaling in vascular endothelial cells in normal and streptozotocin-induced diabetic rats. Hypertension, 2013 Jul , 62 (134-9).
87. Pubmed Wulff H. et al. Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets. J. Cardiovasc. Pharmacol., 2013 Feb , 61 (102-12).
86. Pubmed Sukumaran S. et al. TRPV4 channel activation leads to endothelium-dependent relaxation mediated by nitric oxide and endothelium-derived hyperpolarizing factor in rat pulmonary artery. Pharmacol. Res., 2013 Dec , 78 (18-27).
85. Pubmed Qian A. et al. Role of voltage gated Ca2+ channels in rat visceral hypersensitivity change induced by 2,4,6-trinitrobenzene sulfonic acid. Mol Pain, 2013 , 9 (15).
84. Pubmed Oliván-Viguera A. et al. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3. PLoS ONE, 2013 , 8 (e58614).
83. Pubmed Ferreira R. et al. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells. PLoS ONE, 2013 , 8 (e62345).
82. Pubmed Benton D. et al. The relationship between functional inhibition and binding for K(Ca)2 channel blockers. PLoS ONE, 2013 , 8 (e73328).
81. Pubmed Ide S. et al. Association between genetic polymorphisms in Ca(v)2.3 (R-type) Ca2+ channels and fentanyl sensitivity in patients undergoing painful cosmetic surgery. PLoS ONE, 2013 , 8 (e70694).
80. Pubmed Brennan S. et al. Fetal calcium regulates branching morphogenesis in the developing human and mouse lung: involvement of voltage-gated calcium channels. PLoS ONE, 2013 , 8 (e80294).
79. Pubmed Shakeri B. et al. A quartet of leucine residues in the guanylate kinase domain of CaVβ determines the plasma membrane density of the CaV2.3 channel. J. Biol. Chem., 2012 Sep 21 , 287 (32835-47).
78. Pubmed Müller R. et al. Atropine-sensitive hippocampal θ oscillations are mediated by Cav2.3 R-type Ca²⁺ channels. Neuroscience, 2012 Mar 15 , 205 (125-39).
77. Pubmed Zhao M. et al. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J. Clin. Invest., 2012 Jul 2 , 122 (2672-9).
76. Pubmed Li C. et al. [Distribution diversity of integrins and calcium channels on major human and mouse host cells of Leptospira species]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2012 Jul , 41 (410-7).
75. Pubmed Damkjaer M. et al. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. Br. J. Pharmacol., 2012 Jan , 165 (223-34).
74. Pubmed Trombetta M. et al. CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. PLoS ONE, 2012 , 7 (e32755).
73. Pubmed Gao Y. et al. Dynamin- and Rab5-dependent endocytosis of a Ca2+ -activated K+ channel, KCa2.3. PLoS ONE, 2012 , 7 (e44150).
72. Pubmed Hasenau A. et al. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels. Acta Physiol (Oxf), 2011 Sep , 203 (117-26).
71. Pubmed Cens T. et al. Two sets of amino acids of the domain I of Cav2.3 Ca(2+) channels contribute to their high sensitivity to extracellular protons. Pflugers Arch., 2011 Aug , 462 (303-14).
70. Pubmed Zaman T. et al. Cav2.3 channels are critical for oscillatory burst discharges in the reticular thalamus and absence epilepsy. Neuron, 2011 Apr 14 , 70 (95-108).
69. Pubmed Rijkers K. et al. Polymorphisms in CACNA1E and Camk2d are associated with seizure susceptibility of Sprague-Dawley rats. Epilepsy Res., 2010 Sep , 91 (28-34).
68. Pubmed Köhler R. et al. Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice. Pflugers Arch., 2010 May , 459 (969-76).
67. Pubmed Vick K. et al. In vivo pharmacological manipulation of small conductance Ca(2+)-activated K(+) channels influences motor behavior, object memory and fear conditioning. Neuropharmacology, 2010 Mar , 58 (650-9).
66. Pubmed Gao Y. et al. Recycling of the Ca2+-activated K+ channel, KCa2.3, is dependent upon RME-1, Rab35/EPI64C, and an N-terminal domain. J. Biol. Chem., 2010 Jun 4 , 285 (17938-53).
65. Pubmed Potier M. et al. Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells. Biochem. Biophys. Res. Commun., 2010 Jun 18 , 397 (42-7).
64. Pubmed González-Gutiérrez G. et al. Swapping the I-II intracellular linker between L-type CaV1.2 and R-type CaV2.3 high-voltage gated calcium channels exchanges activation attributes. Channels (Austin), 2010 Jan , 4 (42-50).
63. Pubmed Köhler R. et al. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease. Expert Opin. Ther. Targets, 2010 Feb , 14 (143-55).
62. Pubmed Schlichter L. et al. The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro. J Neuroinflammation, 2010 , 7 (4).
61. Pubmed Sones W. et al. Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels. Br. J. Pharmacol., 2009 Sep , 158 (521-31).
60. Pubmed Lewis B. et al. Cloning and characterization of voltage-gated calcium channel alpha1 subunits in Xenopus laevis during development. Dev. Dyn., 2009 Nov , 238 (2891-902).
59. Pubmed Wölfle S. et al. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo. Cardiovasc. Res., 2009 Jun 1 , 82 (476-83).
58. Pubmed Grgic I. et al. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery. Br. J. Pharmacol., 2009 Jun , 157 (509-26).
57. Pubmed Sankaranarayanan A. et al. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol. Pharmacol., 2009 Feb , 75 (281-95).
56. Pubmed Köhler R. et al. Single-nucleotide polymorphisms in vascular Ca(2+)-activated K (+)-channel genes and cardiovascular disease. , 2009 Dec 31 , ().
55. Pubmed Chantome A. et al. KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility. Exp. Cell Res., 2009 Dec 10 , 315 (3620-30).
54. Pubmed Nyholt D. et al. A high-density association screen of 155 ion transport genes for involvement with common migraine. Hum. Mol. Genet., 2008 Nov 1 , 17 (3318-31).
53. Pubmed Chung G. et al. Modulation of CaV2.3 calcium channel currents by eugenol. J. Dent. Res., 2008 Feb , 87 (137-41).
52. Pubmed Gao Y. et al. Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1. J. Biol. Chem., 2008 Apr 4 , 283 (9049-59).
51. Pubmed Salvador-Recatalà V. et al. Atypical properties of a conventional calcium channel beta subunit from the platyhelminth Schistosoma mansoni. BMC Physiol., 2008 , 8 (6).
50. Pubmed Raybaud A. et al. The role of distal S6 hydrophobic residues in the voltage-dependent gating of CaV2.3 channels. J. Biol. Chem., 2007 Sep 21 , 282 (27944-52).
49. Pubmed Weiergräber M. et al. Hippocampal seizure resistance and reduced neuronal excitotoxicity in mice lacking the Cav2.3 E/R-type voltage-gated calcium channel. J. Neurophysiol., 2007 May , 97 (3660-9).
48. Pubmed Murakami M. et al. Modified sympathetic regulation in N-type calcium channel null-mouse. Biochem. Biophys. Res. Commun., 2007 Mar 23 , 354 (1016-20).
47. Pubmed Matthews E. et al. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur. J. Neurosci., 2007 Jun , 25 (3561-9).
46. Pubmed Toro-Castillo C. et al. Muscarinic modulation of Cav2.3 (R-type) calcium channels is antagonized by RGS3 and RGS3T. Am. J. Physiol., Cell Physiol., 2007 Jan , 292 (C573-80).
45. Pubmed Meza U. et al. Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels. Mol. Pharmacol., 2007 Jan , 71 (284-93).
44. Pubmed Kang H. et al. Histidine residues in the IS3-IS4 loop are critical for nickel-sensitive inhibition of the Cav2.3 calcium channel. FEBS Lett., 2007 Dec 22 , 581 (5774-80).
43. Pubmed Muller Y. et al. Variants in the Ca V 2.3 (alpha 1E) subunit of voltage-activated Ca2+ channels are associated with insulin resistance and type 2 diabetes in Pima Indians. Diabetes, 2007 Dec , 56 (3089-94).
42. Pubmed Holmkvist J. et al. Polymorphisms in the gene encoding the voltage-dependent Ca(2+) channel Ca (V)2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion. Diabetologia, 2007 Dec , 50 (2467-75).
41. Pubmed Sun H. et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels. Biophys. J., 2007 Aug 15 , 93 (1175-83).
40. Pubmed Wulff H. et al. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr. Med. Chem., 2007 , 14 (1437-57).
39. Pubmed Pollandt S. et al. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur. J. Neurosci., 2006 Sep , 24 (1733-43).
38. Pubmed Yang S. et al. The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology. Endocr. Rev., 2006 Oct , 27 (621-76).
37. Pubmed Vinet J. et al. Expression pattern of voltage-dependent calcium channel subunits in hippocampal inhibitory neurons in mice. Neuroscience, 2006 Nov 17 , 143 (189-212).
36. Pubmed Kohlmeier K. et al. Transmitter modulation of spike-evoked calcium transients in arousal related neurons: muscarinic inhibition of SNX-482-sensitive calcium influx. Eur. J. Neurosci., 2006 Mar , 23 (1151-62).
35. Pubmed Osanai M. et al. Altered cerebellar function in mice lacking CaV2.3 Ca2+ channel. Biochem. Biophys. Res. Commun., 2006 Jun 9 , 344 (920-5).
34. Pubmed Srivastava S. et al. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1. Mol. Biol. Cell, 2006 Jan , 17 (146-54).
33. Pubmed Natrajan R. et al. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors. Clin. Cancer Res., 2006 Dec 15 , 12 (7284-93).
32. Pubmed Pardo N. et al. Acetylcholine release at neuromuscular junctions of adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) Ca2+ channels. J. Pharmacol. Exp. Ther., 2006 Dec , 319 (1009-20).
31. Pubmed Kaja S. et al. Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of tottering mice. J. Neurophysiol., 2006 Apr , 95 (2698-704).
30. Pubmed Krieger A. et al. The molecular chaperone hsp70 interacts with the cytosolic II-III loop of the Cav2.3 E-type voltage-gated Ca2+ channel. Cell. Physiol. Biochem., 2006 , 17 (97-110).
29. Pubmed Kamp M. et al. Presynaptic 'Ca2.3-containing' E-type Ca channels share dual roles during neurotransmitter release. Eur. J. Neurosci., 2005 Mar , 21 (1617-25).
28. Pubmed Berrou L. et al. The C-terminal residues in the alpha-interacting domain (AID) helix anchor CaV beta subunit interaction and modulation of CaV2.3 channels. J. Biol. Chem., 2005 Jan 7 , 280 (494-505).
27. Pubmed Yang S. et al. Beta-cell CaV channel regulation in physiology and pathophysiology. Am. J. Physiol. Endocrinol. Metab., 2005 Jan , 288 (E16-28).
26. Pubmed Jing X. et al. CaV2.3 calcium channels control second-phase insulin release. J. Clin. Invest., 2005 Jan , 115 (146-54).
25. Pubmed Yang S. et al. CaV2.3 channel and PKClambda: new players in insulin secretion. J. Clin. Invest., 2005 Jan , 115 (16-20).
24. Pubmed Larsen J. et al. Disruption of growth hormone secretion alters Ca2+ current density and expression of Ca2+ channel and insulin-like growth factor genes in rat atria. Am. J. Physiol. Heart Circ. Physiol., 2005 Feb , 288 (H829-38).
23. Pubmed Granados-Gonzalez G. et al. Identification of voltage-dependent Ca2+ channels in sea urchin sperm. FEBS Lett., 2005 Dec 5 , 579 (6667-72).
22. Pubmed Tuteja D. et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol., 2005 Dec , 289 (H2714-23).
21. Pubmed Layton M. et al. Cellular localization of voltage-gated calcium channels and synaptic vesicle-associated proteins in the guinea pig cochlea. J. Mol. Neurosci., 2005 , 27 (225-44).
20. Pubmed Dafi O. et al. Negatively charged residues in the N-terminal of the AID helix confer slow voltage dependent inactivation gating to CaV1.2. Biophys. J., 2004 Nov , 87 (3181-92).
19. Pubmed Klöckner U. et al. The cytosolic II-III loop of Cav2.3 provides an essential determinant for the phorbol ester-mediated stimulation of E-type Ca2+ channel activity. Eur. J. Neurosci., 2004 May , 19 (2659-68).
18. Pubmed D'Ascenzo M. et al. Electrophysiological and molecular evidence of L-(Cav1), N- (Cav2.2), and R- (Cav2.3) type Ca2+ channels in rat cortical astrocytes. Glia, 2004 Mar , 45 (354-63).
17. Pubmed Bannister R. et al. Differential modulation of CaV2.3 Ca2+ channels by Galphaq/11-coupled muscarinic receptors. Mol. Pharmacol., 2004 Feb , 65 (381-8).
16. Pubmed Yokoyama K. et al. Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance. Eur. J. Neurosci., 2004 Dec , 20 (3516-9).
15. Pubmed Lu Z. et al. Arrhythmia in isolated prenatal hearts after ablation of the Cav2.3 (alpha1E) subunit of voltage-gated Ca2+ channels. Cell. Physiol. Biochem., 2004 , 14 (11-22).
14. Pubmed Liang H. et al. Unified mechanisms of Ca2+ regulation across the Ca2+ channel family. Neuron, 2003 Sep 11 , 39 (951-60).
13. Pubmed Hajela R. et al. Comparative effects of methylmercury and Hg(2+) on human neuronal N- and R-type high-voltage activated calcium channels transiently expressed in human embryonic kidney 293 cells. J. Pharmacol. Exp. Ther., 2003 Sep , 306 (1129-36).
12. Pubmed Waka N. et al. Localization of the calcium channel subunits Cav1.2 (alpha1C) and Cav2.3 (alpha1E) in the mouse organ of Corti. Histol. Histopathol., 2003 Oct , 18 (1115-23).
11. Pubmed Kohn A. et al. Specific sites in the Beta Interaction Domain of a schistosome Ca2+ channel beta subunit are key to its role in sensitivity to the anti-schistosomal drug praziquantel. Parasitology, 2003 Oct , 127 (349-56).
10. Pubmed Cohen R. et al. The C2A domain of synaptotagmin alters the kinetics of voltage-gated Ca2+ channels Ca(v)1.2 (Lc-type) and Ca(v)2.3 (R-type). J. Biol. Chem., 2003 Mar 14 , 278 (9258-66).
9. Pubmed Dietrich D. et al. Functional specialization of presynaptic Cav2.3 Ca2+ channels. Neuron, 2003 Jul 31 , 39 (483-96).
8. Pubmed Takei T. et al. Anesthetic sensitivities to propofol and halothane in mice lacking the R-type (Cav2.3) Ca2+ channel. Anesth. Analg., 2003 Jul , 97 (96-103, table of contents).
7. Pubmed Carlson A. et al. CatSper1 required for evoked Ca2+ entry and control of flagellar function in sperm. Proc. Natl. Acad. Sci. U.S.A., 2003 Dec 9 , 100 (14864-8).
6. Pubmed Leroy J. et al. Ca2+-sensitive regulation of E-type Ca2+ channel activity depends on an arginine-rich region in the cytosolic II-III loop. Eur. J. Neurosci., 2003 Aug , 18 (841-55).
5. Pubmed Bergquist F. et al. Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis. Neuroscience, 2003 , 120 (757-64).
4. Pubmed Stephens G. et al. The Cav2.1/alpha1A (P/Q-type) voltage-dependent calcium channel mediates inhibitory neurotransmission onto mouse cerebellar Purkinje cells. Eur. J. Neurosci., 2001 May , 13 (1902-12).
3. Pubmed Joux N. et al. High voltage-activated Ca2+ currents in rat supraoptic neurones: biophysical properties and expression of the various channel alpha1 subunits. J. Neuroendocrinol., 2001 Jul , 13 (638-49).
2. Pubmed Berrou L. et al. Molecular determinants of inactivation within the I-II linker of alpha1E (CaV2.3) calcium channels. Biophys. J., 2001 Jan , 80 (215-28).
1. Pubmed Wennemuth G. et al. CaV2.2 and CaV2.3 (N- and R-type) Ca2+ channels in depolarization-evoked entry of Ca2+ into mouse sperm. J. Biol. Chem., 2000 Jul 14 , 275 (21210-7).